SUBSCRIBE
SUBSCRIBE
Tristan Manalac

Tristan Manalac

Contributing Writer | News

Tristan is an independent science writer based in Metro Manila, with more than eight years of experience writing about medicine, biotech and science. Being formally trained in molecular biology, he once dreamed of collecting degrees and starting his own lab. But these days, he finds his greatest joy in a bottle of beer and a beautiful sentence. He can be reached at tristan.manalac@biospace.com, tristan@tristanmanalac.com or on LinkedIn.

Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Manufacturing
Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment
Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.
May 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Lungs health and pulmonology as a respiratory medicine conept for pulmonary science and lung cancer or respiration disease and bronchi breathing or asthma symbol in a 3D illustration style.
Lung Cancer
AbbVie’s ADC Nabs Accelerated Approval for Lung Cancer
AbbVie’s Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who have received prior lines of treatment.
May 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
GSK secures rights to Boston Pharmaceuticals’ efimosfermin alfa, which the pharma plans to develop for fatty liver diseases such as metabolic dysfunction-associated steatohepatitis and alcohol-related liver disease.
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Crumpled paper balls fly into a miniature bucket, the concept of searching for new ideas
Lung cancer
GSK, iTeos Abandon TIGIT Therapy, Adding to Long List of Recent Class Failures
Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck squamous cell carcinoma.
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman team walking at a crossroads following the arrows
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Manufacturing
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Bayer office in Basel, Switzerland
Earnings
Bayer’s Continued Restructuring Claims 2,000 Jobs and Thins Management Layers
Meanwhile, Bayer CEO Bill Anderson said Donald Trump’s Most Favored Nations policy could present an opportunity for European countries to make sure they are also funding their “fair share” of biopharma innovation.
May 13, 2025
 · 
3 min read
 · 
Tristan Manalac
Roche's signage at its office in France
Manufacturing
Roche’s Genentech Earmarks $700M for North Carolina Plant as Billion-Dollar US Pledge Hangs in Balance
The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that could change if certain yet-unspecified policies are implemented that could “harm our industry’s ability to operate and innovate in America.”
May 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Sign of U.S. Department of Health & Huma
Drug pricing
CMS Prepares for Third Cycle of Drug Negotiations as Trump Intensifies Push To Lower Prices
The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in 2028.
May 13, 2025
 · 
3 min read
 · 
Tristan Manalac
red figurine of a man stands aside from the crowd of people. Asociality, sociopathy. Rejected from society, lonely. Development of leadership and social qualities. Infected, fear and misunderstanding.
Pharmacy benefit managers
Trump’s Most Favored Nation Policy Sparks PBM Selloff
The Most Favored Nation directive would allow drugmakers to directly sell their products to patients at a lower cost, cutting out what President Donald Trump called “the middlemen.”
May 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Save money and investment concept. Closeup piggy bank and silver coins falling. 3d rendering illustration
Funding
Azafaros Raises $150M To Target Rare Neuro-Metabolic Diseases
Azafaros will use the Series B haul to push lead asset nizubaglustat into late-stage studies for Niemann-Pick disease Type C and GM1/GM2 gangliosidoses later this year.
May 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Stand out from the crowd and different creative idea concepts , Longest light ladder glowing and aiming high to goal target among other short ladders on green background with shadows . 3D rendering.
Obesity
Lilly’s Zepbound Secures “Superior Benefit-Risk Ratio” Over Novo’s Wegovy
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of safety, according to newly released comprehensive tolerability data—findings that Leerink analysts say confirm the GLP-1 drug’s edge in the closely watched market race.
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Roche's tower in Shanghai, China
Manufacturing
Roche Makes $300M China Production Promise After Multibillion US Investment
Last month, Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative photo collage or modern art collage featuring symbols of law and justice. Hand holding a gavel and scales of justice with books about law.
Legal
BMS, Sanofi Settle Plavix Suit With Hawaii for $700M
The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform patients in the state that the drug is likely to be less effective for them.
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Background with halftone hand hold magnifier and torn papers. Collage element for search concept. Find information in internet browser.
Vaccines
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ongoing.
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More